Globus Medical (GMED) Net Income towards Common Stockholders (QoQ) (2011 - 2026)
Globus Medical (GMED) Net Income towards Common Stockholders (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Globus Medical | 10.59 Bn | 9.96 Bn | 525.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.59% |
| Dec 31, 2025 | 18.18% |
| Sep 30, 2025 | -41.35% |
| Jun 30, 2025 | 168.81% |
| Mar 31, 2025 | 184.71% |
| Dec 31, 2024 | -48.87% |
| Sep 30, 2024 | 63.21% |
| Jun 30, 2024 | 543.64% |
| Mar 31, 2024 | -147.62% |
| Dec 31, 2023 | 1,406.41% |
| Sep 30, 2023 | -98.27% |
| Jun 30, 2023 | 17.47% |
| Mar 31, 2023 | 77.14% |
| Dec 31, 2022 | -41.53% |
| Sep 30, 2022 | -13.11% |
| Jun 30, 2022 | 43.34% |
| Mar 31, 2022 | 122.44% |
| Dec 31, 2021 | -459.48% |
| Sep 30, 2021 | 13.64% |
| Jun 30, 2021 | -8.35% |